Kiichiro Ninomiya
0000-0002-2134-2865
Publication & Citation Trends
Publications
0 total
Corrigendum to 'Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02-A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC' [Journal of Thoracic Oncology Volume 20 Issue 12 (2025) 1814-1828].
Cited by 0
Semantic Scholar
Abstract CT248: Zidesamtinib in patients with ROS1+ NSCLC previously treated with repotrectinib or taletrectinib
Cited by 0
Semantic Scholar
Final analysis results and patient-reported outcomes from DESTINY-Lung02-a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small cell lung cancer.
Cited by 7
Semantic Scholar
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study
Cited by 3
Semantic Scholar
Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases
Cited by 5
Semantic Scholar
Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME).
Cited by 1
Semantic Scholar
A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET). OA
Cited by 8
Semantic Scholar
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study OA
Cited by 0
Semantic Scholar
Key Update in 2025 Japanese Lung Cancer Society Guidelines
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(124)
Lung Cancer Research Studies
(55)
Cancer Immunotherapy and Biomarkers
(42)
Lung Cancer Diagnosis and Treatment
(28)
HER2/EGFR in Cancer Research
(20)
Affiliations
Okayama Shoka University
Novartis (Switzerland)
Okayama University of Science
Okayama University
Tokyo Kasei University